Lilly cuts prices for some insulin products; a CRISPR patent fight redux with new gene editing tools
Taking stock of the drug industry, from the lab to the medicine chest March 1, 2023 Check out STAT+ Sponsored By By Ed Silverman Pharmalot C...Read More